FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891762349> ?p ?o ?g. }

• W2891762349 endingPage "159" @default.
• W2891762349 startingPage "152" @default.
• W2891762349 abstract "Background: Cordycepin is a small molecule from medicinal mushroom Cordyceps, which has been reported for anticancer properties. </P><P> Objective: In this study, we have focused on the investigation of cordycepin effect on cervical cancer cells with further clarification of possible molecular mechanism. </P><P> Method: We have used cell viability and cell counting assay for cytotoxic effect of cordycepin, flow cytometric assay of apoptosis and cell cycle, and quantitative PCR (qPCR) and Western blotting for the determination of target gene expression. Molecular docking and Molecular dynamics simulation were used for in silico analysis of cordycepin affinity to target protein(s). </P><P> Results: Treatment of cordycepin controlled SiHa and HeLa cervical cancer cell growth, increased the rate of their apoptosis, and interfered with cell cycle, specifically elongated S-phase. qPCR results indicated that there was a downregulation of cell cycle proteins CDK-2, CYCLIN-A2 and CYCLIN-E1 in mRNA level by cordycepin treatment but no significant change was observed in pro-apoptotic or antiapoptotic proteins. The intracellular reactive oxygen species (ROS) level in cordycepin treated cells was increased significantly, implying that apoptosis might be induced by ROS. Western blot analysis confirmed significant decrease of Cdk-2 and mild decrease of Cyclin-E1 and Cyclin-A2 by cordycepin, which might be responsible for regulating cell cycle. Molecular docking indicated high binding affinity of cordycepin against Cdk-2. Molecular dynamics simulation further confirmed that the docked pose of cordycepin-Cdk-2 complex remained within the binding pocket for 10 ns. </P><P> Conclusion: Our study suggests that cordycepin is effective against cervical cancer cells, and regulating cell cycle via cell cycle proteins, especially downregulating Cdk-2, and inducing apoptosis by generating ROS are among the mechanisms of anticancer activities of cordycepin." @default.
• W2891762349 created "2018-09-27" @default.
• W2891762349 creator A5004619720 @default.
• W2891762349 creator A5013078087 @default.
• W2891762349 creator A5019969644 @default.
• W2891762349 creator A5022994950 @default.
• W2891762349 creator A5064771827 @default.
• W2891762349 creator A5075645075 @default.
• W2891762349 creator A5078721934 @default.
• W2891762349 date "2019-01-21" @default.
• W2891762349 modified "2023-10-18" @default.
• W2891762349 title "Cordycepin Downregulates Cdk-2 to Interfere with Cell Cycle and Increases Apoptosis by Generating ROS in Cervical Cancer Cells: in vitro and in silico Study" @default.
• W2891762349 cites W1550020065 @default.
• W2891762349 cites W1872394536 @default.
• W2891762349 cites W1889453500 @default.
• W2891762349 cites W1969039566 @default.
• W2891762349 cites W1980337077 @default.
• W2891762349 cites W1989254646 @default.
• W2891762349 cites W2005583960 @default.
• W2891762349 cites W2010631370 @default.
• W2891762349 cites W2032599628 @default.
• W2891762349 cites W2032982304 @default.
• W2891762349 cites W2038407368 @default.
• W2891762349 cites W2046634887 @default.
• W2891762349 cites W2053775329 @default.
• W2891762349 cites W2067174909 @default.
• W2891762349 cites W2083799886 @default.
• W2891762349 cites W2098376669 @default.
• W2891762349 cites W2150755837 @default.
• W2891762349 cites W2153015609 @default.
• W2891762349 cites W2195691345 @default.
• W2891762349 cites W2320916746 @default.
• W2891762349 cites W2404280981 @default.
• W2891762349 cites W2442673105 @default.
• W2891762349 cites W2524662486 @default.
• W2891762349 cites W2559969733 @default.
• W2891762349 cites W2566010315 @default.
• W2891762349 cites W2572539461 @default.
• W2891762349 cites W2576810921 @default.
• W2891762349 cites W2581019715 @default.
• W2891762349 cites W2586048847 @default.
• W2891762349 cites W2588789796 @default.
• W2891762349 cites W2608738389 @default.
• W2891762349 cites W2611197556 @default.
• W2891762349 cites W2760958557 @default.
• W2891762349 cites W2766064424 @default.
• W2891762349 cites W2918098512 @default.
• W2891762349 doi "https://doi.org/10.2174/1568009618666180905095356" @default.
• W2891762349 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30182857" @default.
• W2891762349 hasPublicationYear "2019" @default.
• W2891762349 type Work @default.
• W2891762349 sameAs 2891762349 @default.
• W2891762349 citedByCount "17" @default.
• W2891762349 countsByYear W28917623492019 @default.
• W2891762349 countsByYear W28917623492020 @default.
• W2891762349 countsByYear W28917623492021 @default.
• W2891762349 countsByYear W28917623492022 @default.
• W2891762349 countsByYear W28917623492023 @default.
• W2891762349 crossrefType "journal-article" @default.
• W2891762349 hasAuthorship W2891762349A5004619720 @default.
• W2891762349 hasAuthorship W2891762349A5013078087 @default.
• W2891762349 hasAuthorship W2891762349A5019969644 @default.
• W2891762349 hasAuthorship W2891762349A5022994950 @default.
• W2891762349 hasAuthorship W2891762349A5064771827 @default.
• W2891762349 hasAuthorship W2891762349A5075645075 @default.
• W2891762349 hasAuthorship W2891762349A5078721934 @default.
• W2891762349 hasConcept C124320809 @default.
• W2891762349 hasConcept C1491633281 @default.
• W2891762349 hasConcept C153911025 @default.
• W2891762349 hasConcept C185592680 @default.
• W2891762349 hasConcept C190283241 @default.
• W2891762349 hasConcept C2777366897 @default.
• W2891762349 hasConcept C2780066241 @default.
• W2891762349 hasConcept C29537977 @default.
• W2891762349 hasConcept C53227056 @default.
• W2891762349 hasConcept C55493867 @default.
• W2891762349 hasConcept C62112901 @default.
• W2891762349 hasConcept C86803240 @default.
• W2891762349 hasConcept C95444343 @default.
• W2891762349 hasConceptScore W2891762349C124320809 @default.
• W2891762349 hasConceptScore W2891762349C1491633281 @default.
• W2891762349 hasConceptScore W2891762349C153911025 @default.
• W2891762349 hasConceptScore W2891762349C185592680 @default.
• W2891762349 hasConceptScore W2891762349C190283241 @default.
• W2891762349 hasConceptScore W2891762349C2777366897 @default.
• W2891762349 hasConceptScore W2891762349C2780066241 @default.
• W2891762349 hasConceptScore W2891762349C29537977 @default.
• W2891762349 hasConceptScore W2891762349C53227056 @default.
• W2891762349 hasConceptScore W2891762349C55493867 @default.
• W2891762349 hasConceptScore W2891762349C62112901 @default.
• W2891762349 hasConceptScore W2891762349C86803240 @default.
• W2891762349 hasConceptScore W2891762349C95444343 @default.
• W2891762349 hasIssue "2" @default.
• W2891762349 hasLocation W28917623491 @default.
• W2891762349 hasLocation W28917623492 @default.
• W2891762349 hasOpenAccess W2891762349 @default.
• W2891762349 hasPrimaryLocation W28917623491 @default.
• W2891762349 hasRelatedWork W2352284239 @default.

• next